ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

309 hedge funds and large institutions have $9B invested in Alnylam Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 122 increasing their positions, 80 reducing their positions, and 39 closing their positions.

Holders
309
Holders Change
+17
Holders Change %
+5.82%
% of All Funds
7.08%
Holding in Top 10
9
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-25%
% of All Funds
0.21%
New
57
Increased
122
Reduced
80
Closed
39
Calls
$106M
Puts
$56.4M
Net Calls
+$49.7M
Net Calls Change
+$46.2M

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$1.16B
2
ACA
2
Avoro Capital Advisors
New York
$69M
3
MC
3
Maverick Capital
Texas
$67.1M
4
JPMorgan Chase & Co
4
JPMorgan Chase & Co
New York
$62.3M
5
PA
5
Perceptive Advisors
New York
$182M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$514M
2
BlackRock
2
BlackRock
New York
$605M
3
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$10.1M
4
Lord, Abbett & Co
4
Lord, Abbett & Co
New Jersey
$0
5
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.49B 15,078,361 +52,653 +0.4%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$1.16B 11,784,320 +2,181,158 +23%
Vanguard Group
3
Vanguard Group
Pennsylvania
$742M 7,538,513 +95,107 +1%
BlackRock
4
BlackRock
New York
$605M 6,139,270 -1,038,792 -14%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$514M 5,213,963 -7,355,371 -59%
Dodge & Cox
6
Dodge & Cox
California
$458M 4,654,701 -38,140 -0.8%
Baillie Gifford & Co
7
Baillie Gifford & Co
United Kingdom
$417M 4,231,881 +397,668 +10%
State Street
8
State Street
Massachusetts
$222M 2,250,242 +118,425 +6%
PA
9
Perceptive Advisors
New York
$182M 1,846,911 +566,109 +44%
UBS AM
10
UBS AM
Illinois
$134M 1,358,599 +17,428 +1%
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$134M 1,356,408 +448,362 +49%
O
12
OrbiMed
New York
$125M 1,265,966 – –
Morgan Stanley
13
Morgan Stanley
New York
$124M 1,257,042 -3,381 -0.3%
BB
14
BB Biotech
Switzerland
$112M 1,140,538 +129,200 +13%
GGHC
15
Gilder Gagnon Howe & Co
New York
$108M 1,094,716 -115,706 -10%
Goldman Sachs
16
Goldman Sachs
New York
$81.6M 828,899 -181,839 -18%
Norges Bank
17
Norges Bank
Norway
$80.6M 818,236 +14,273 +2%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$79.4M 806,745 +41,401 +5%
1WCM
19
12 West Capital Management
New York
$72.4M 735,000 +35,000 +5%
PAMU
20
Pictet Asset Management (UK)
United Kingdom
$72.3M 734,335 +88,297 +14%
ACA
21
Avoro Capital Advisors
New York
$69M 700,100 +700,100 New
MC
22
Maverick Capital
Texas
$67.1M 681,354 +681,354 New
First Trust Advisors
23
First Trust Advisors
Illinois
$65M 659,766 +123,099 +23%
AG
24
Artal Group
Luxembourg
$64M 650,000 +50,000 +8%
BM
25
Bridger Management
New York
$63.3M 642,466 +92,834 +17%
1
2 3 4 5